Crowdonomics
WatchlistPortfolio
CytexOrtho

Reg CF · Common Stock · Oct 2022

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$304K / $1.1M max
28% of ceiling · target hit day 2
Investors
258
$1.9K avg
Post-money valuation
$18.7M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$496K$248K$0
2591300
Oct 26, 2022 · openedFeb 18, 2023 · last reading
Target ($10K) hit — Oct 28, 2022, day 2Deadline Jan 24, 2023

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2021 · hover for source
$1.8M
−$23K
FY2021
RevenueNet income
Metric
FY2021 unaudited
Income statement
Revenue
$1,836,602
Cost of goods sold
$1,263,476
Gross margin
31%
Net income
-$22,653
Taxes paid
$0
Balance sheet
Cash
$489,299
Accounts receivable
$66,611
Total assets
$626,138
Short-term debt
$144,543
Long-term debt
$250,000
Total liabilities
$394,543
Other
Headcount
8

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$18.2M
Post-money$18.7M
Price / share$2.00
Shares offered5,000

Perks

Invest within the first 72 hours and receive 20% bonus shares · until Oct 28, 202220% bonus

Offering details

Target$10,000
Max$1,070,000
Min investment$250
OpenedOct 26, 2022
DeadlineJan 24, 2023
ClosedJan 24, 2023
Days active90

Links & provenance

Campaign pageSEC filing
Source: Manual
0001665160-22-002814
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.